About
Profile
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better.
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
SYK
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Stryker 2023 earnings guidance comes in above consensus
- Stryker Non-GAAP EPS of $2.14 beats by $0.13, revenue of $4.8B beats by $240M
- 5 stocks to watch on Monday: First Republic Bank, SoFi and more
- Stryker Q1 2023 Earnings Preview
- Pharmas, medtechs dominate list of innovation leaders thanks to patents
- Stryker wins FDA nod for Q Guidance System in head surgery
- Stryker declares $0.75 dividend
- Ambulatory surgery centers, robotics seen as trends for orthopedic devices in 2023
- Stryker up 4% following Q4 top and bottom line beats; 2023 EPS estimate above consensus
- Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M
- Stryker Q4 2022 Earnings Preview
- Stryker initiated at sector weight by KeyBanc on limited upside potential
- Becton upgraded; Baxter downgraded as BofA shuffles MedTech ratings
- Goldman Sachs highlights key healthcare themes for 2023
- EU wants to delay medical device law amid supply challenges - Reuters
- Stryker lifts dividend by 7.9% to $0.75/share
- Stryker cut to Hold at Canaccord Genuity after Q3 earnings miss
- Stryker sees Q3 net income surge 86% YoY, but still misses on bottom line
- Stryker Non-GAAP EPS of $2.12 misses by $0.11, revenue of $4.5B beats by $40M
- With medical devices market expected to soar, here are companies set to benefit the most
PEERS
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| January 27, 2022 | 2.71 / 2.73 | 4.7B / 4.65B |
Beat! |
| October 28, 2021 | 2.2 / 2.28 | 4.16B / 4.22B | |
| July 27, 2021 | 2.25 / 2.14 | 4.29B / 4.14B |
Beat! |
| April 27, 2021 | 1.93 / 1.99 | 3.95B / 3.95B | |
| January 27, 2021 | 2.81 / 2.55 | 4.26B / 4.33B | |
| October 30, 2020 | 2.14 / 1.41 | 3.74B / 3.41B |
Beat! |
| July 30, 2020 | 0.64 / 0.56 | 2.76B / 2.59B |
Beat! |
| April 30, 2020 | 1.84 / 1.81 | 3.59B / 3.57B |
Beat! |
| January 28, 2020 | 2.49 / 2.46 | 4.13B / 4.11B |
Beat! |
| October 29, 2019 | 1.91 / 1.9 | 3.59B / 3.58B |
Beat! |
| July 25, 2019 | 1.98 / 1.94 | 3.65B / 3.6B |
Beat! |
| April 23, 2019 | 1.88 / 1.84 | 3.52B / 3.52B | |
| January 29, 2019 | 2.18 / 2.15 | 3.8B / 3.74B |
Beat! |
| October 25, 2018 | 1.69 / 1.68 | 3.24B / 3.26B | |
| July 24, 2018 | 1.76 / 1.73 | 3.32B / 3.32B | |
| April 26, 2018 | 1.68 / 1.6 | 3.24B / 3.2B |
Beat! |
| January 30, 2018 | 1.96 / 1.95 | 3.47B / 3,396M |
Beat! |
| October 26, 2017 | 1.52 / 1.50 | 3.01B / 2,968M |
Beat! |
| July 27, 2017 | 1.52 / 1.52 | 3.01B / 2.98B |
Beat! |
| April 25, 2017 | 1.48 / 1.51 | 2.96B / - |
Beat! |